BeneChill Receives Frost & Sullivan Award for Intranasal Cooling System for Therapeutic Hypothermia
January 22, 2014
January 22, 2014 — BeneChill Inc. received the 2014 Frost & Sullivan Award for Technology Innovation Leadership for its RhinoChill intranasal cooling system.
BeneChill's RhinoChill is a nasopharyngeal device that can induce and sustain therapeutic hypothermia during active resuscitation after cardiac arrest. The system is noninvasive, time critical and can be used by nonmedical personnel to prevent brain damage associated with cardiac arrest.
RhinoChill is portable and battery-operated with a control unit, coolant bottle and a transnasal cooling catheter to facilitate use outside of hospital settings. The technology enables brain cooling close to the time of cerebral ischemic events, including in the absence of blood circulation. RhinoChill's technology initially targets brain cooling and then body cooling during cardiac arrest and after resuscitation.
The technology maintains therapeutic hypothermia brain temperatures by deploying two 10 cm long nasal catheter prongs that spray a mist of liquid proprietary coolant into the nasal cavity. The sprayed coolant evaporates on contact with the internal nares of the skull and facilitates rapid heat transfer. Lungs expel the coolant as inert and nontoxic gas.
RhinoChill’s operating input voltage is 10 to 18 V DC, and the control unit draws little current to enable battery operation. Its dimensions are 39 x 26 x 16 cm and it weighs approximately 5 to 9 kg. The system's components can connect in 30 to 60 seconds and can deploy immediately. RhinoChill features an auto shut off that is responsive to pressure in the nasal cavity beyond a threshold.
BeneChill plans to expand the technology to other fields such as traumatic brain injury, neuroradiology, neurosurgery and cardiac surgery.
Each year, Frost & Sullivan presents this award to the company that has demonstrated uniqueness in developing and leveraging new technologies, which significantly impacts both the functionality and the customer value of the new products and applications. The award lauds the high R&D spend towards innovation, its relevance to the industry and the positive impact on brand perception.
For more information: www.benechill.com, www.frost.com
More like this
- BeneChill Launches European Study of Intra-Arrest Cooling
- Partnership Formed to Bring Therapeutic Hypothermia System to Europe
- Nasal Cavity Hypothermia Device Receives CE Mark for European Sales
- First Intra-Arrest Cooling Study to be Presented at AHA
- Targeted Brain Cooling May Improve Outcomes, Survival for Cardiac Arrest Patients